A Pfizer gene therapy for the rare muscle-wasting disease Duchenne muscular dystrophy did not help patients’ ability to walk or stand up in a pivotal clinical trial. The pharmaceutical giant is still ...
The FDA is raising efficacy questions over Lundbeck and Otsuka’s proposed combination of their Rexulti with Viatris’ Zoloft as a treatment for post-traumatic stress disorder (PTSD). For an upcoming ...
GSK’s cobolimab has become the latest anti-TIM-3 antibody to flunk a crucial oncology test, as the pharma absorbs a more than $600 million hit from its anti-TIGIT drug failure. The British Big Pharma ...
BioVie Inc. (BIVI) Securities Class Action: The litigation focuses on the propriety of BioVie’s disclosures concerning its adherence to Good Clinical Practice (“GCP”) and protocols related to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback